|
|
|
Back to Financial results |
|
|
|
|
| ARVIND REMEDIES LIMITED |
| |
|
|
|
| UNAUDITED FINANCIAL
RESULTS FOR THE QUARTER ENDED JUNE 30,2008 |
| |
|
|
|
| |
RS. IN LAKHS |
| PARTICULARS |
Three
months ended 30-6-2008 |
Three months ended 30-6-2007 |
Year ended 31-03-2008 |
| |
Unaudited |
Unaudited |
Audited |
| 1. (a)
Net Sales |
5103.45 |
4047.22 |
20151.04 |
| (b) Other Operating Income |
3.29 |
2.58 |
(2583.89) |
| Total
Operating Income |
5106.74 |
4049.80 |
17567.15 |
| |
|
|
19.66 |
| 2.
Expenditure |
|
|
17586.81 |
| a)
(Increase)/Decrease in stock |
(176.58) |
(255.62) |
(435.01) |
| b) Consumption of Materials |
4472.62 |
3587.91 |
15283.14 |
| c) Purchase of Traded Goods |
- |
- |
30.69 |
| d) Employee Cost |
103.65 |
92.52 |
441.04 |
| e) Depreciation |
48.01 |
43.64 |
179.71 |
| f) Other expenditure |
146.16 |
130.54 |
649.87 |
| g) Total
(a) to (f) |
4593.86 |
3598.99 |
16149.44 |
| |
|
|
|
| 3.
Interest |
198.46 |
163.37 |
748.02 |
| 7.
Profit after interst but before Exceptional items(5-6) |
314.42 |
287.44 |
689.35 |
| 8.
Execptional Items |
|
|
|
| 9.
Profit from Ordinary activities before Tax (8-9) |
314.42 |
287.44 |
689.35 |
| 10.
Provision for Taxation |
|
|
|
| Income Tax(Including Fringe Benefit
Tax) |
30.00 |
26.73 |
147.23 |
| Earlier Years |
- |
- |
- |
| Deferred Tax |
(8.67) |
(12.72) |
29.11 |
| Wealth Tax |
- |
- |
0.33 |
| 11.
Profit from Ordinary activities after Tax |
293.09 |
273.43 |
512.68 |
| 12.Extraordinary
Items (net of tax expense) |
- |
- |
- |
| 13.Net
Profit for the Period |
293.09 |
273.43 |
512.68 |
| 14.Paid-up
Equity Share Capital |
2600.50 |
2600.50 |
2600.50 |
| (face value Re.1/- per Share) |
|
|
|
| 15.Reserves
excluding Revaluation Reserve |
- |
- |
1881.86 |
| Basic and Diluted Earnings Per Share before and after
extraordinary Items (Rs.) |
0.11 |
0.11 |
0.20 |
| Public
Shareholding |
|
|
|
| Number
of shares |
194205340 |
194205340 |
194205340 |
| Percentage
of Shareholding |
74.68% |
74.68% |
74.68% |
| |
|
|
|
| Note : |
|
|
|
| 1. The Company
operates in only one business segment namely Formulations |
|
| 2. Previous period figures have been regrouped /
rearranged wherever necessary to confirm to the |
| current periods classification. |
|
|
|
| 3.
The above results were reviewed by the audit committee and taken on record at
the meeting of the |
| Board of Directors held on August
30,2008 |
|
|
|
| 5.
During the quarter 'NIL' investor
compliants were received and disposed off.
There were no |
| investor compliants pending for the redressal as at
the commencement and end of the quarter. |
| 6. The above
results for the quarter ended June30,2008, have been subjected to a Limited |
|
| Review by the statutory auditors as per
listing agreement with the stock exchange. |
|
| |
|
|
|
| |
|
|
|
| Chennai - 600 084 |
|
For
ARVIND REMEDIES LTD |
| Date: August 30, 2008 |
|
|
|
| |
|
DR.B.Arvind
Shah |
| |
|
CEO
& Managing Director |
|
|
|
|
|
|
|
Back to
Financial results |
|
|
|
|